Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain
Chronic Administration of Opioids in Cancer Chronic Pain:an Open Prospective Study on Efficacy, Safety and Pharmacogenetic Factors Influence.
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
Suspended
difficulties in patients enrolment
This PHASE4 trial investigates Chronic Pain and is currently suspended. Fondazione IRCCS Policlinico San Matteo di Pavia leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Suspended PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Suspended PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Suspended PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Suspended PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Suspended PHASE4
First recorded
Feb 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione IRCCS Policlinico San Matteo di Pavia
- University of Pavia
For direct contact, visit the study record on ClinicalTrials.gov .